Developing and evaluating stereotactic lung RT trials: What we should know about the influence of inhomogeneity corrections on dose

Radiation Oncology

Volumn 3, Issue 1, 2008, Pages

  Schuring, Danny ^a   Hurkmans, Coen W ^a  

^a CATHARINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY; MONTE CARLO METHOD; ONCOLOGY; RADIATION DOSE; RADIOMETRY; RADIOSURGERY;

ALGORITHMS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS AS TOPIC; HUMANS; LUNG NEOPLASMS; MONTE CARLO METHOD; RADIATION ONCOLOGY; RADIOMETRY; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RESEARCH DESIGN;

EID: 49749088670     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-3-21     Document Type: Article

References (18)

1. Onishi H Shirato H Nagata Y Hiraoka M Fujino M Gomi K Niibe Y Karasawa K Hayakawa K Takai Y Kimura T Takeda A Ouchi A Hareyama M Kokubo M Hara R Itami J Yamada K Araki T: Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2:S94-100. 10.1097/JTO.0b013e318074de34 17603311
2. Timmerman R Papiez L McGarry Likes L DesRosiers C Frost S Williams M: Extracranial stereotactic radioablation - results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003, 124:1946-1955. 10.1378/chest.124.5.1946 14605072
3. Lagerwaard FJ Haasbeek CJA Smit EF Slotman BJ Senan S: Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 70:685-692. http://linkinghub.elsevier.com/retrieve/pii/ S0360301607044689 18164849
4. Timmerman RD Michalski J Galvin J Fowler JF Choy H gore E johnstone D: RTOG 0236: A phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I/II non-small cell lung cancer. RTOG 2006
5. Nishio T Kunieda E Shirato H Ishikura S Onishi H Tateoka K Hiraoka M Narita Y Ikeda M Goka T: Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403). Phys Med Biol 2006, 51:5409-5417. 10.1088/0031-9155/51/21/ 002 17047260
6. Knöös T Wieslander E Cozzi L Brink C Fogliata A Albers D Nyström H Lassen S: Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations. Phys Med Biol 2006, 51:5785-5807. 10.1088/0031-9155/51/22/ 005 17068365
7. Lax I Panettieri V Wennberg B Amor DM Naslund I Baumann P Gagliardi G: Dose distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions. Acta Oncol 2006, 45:978-988. 10.1080/ 02841860600900050 16982567
8. Jones AO Das IJ: Comparison of inhomogeneity correction algorithms in small photon fields. Med Phys 2005, 32:766-776. 10.1118/1.1861154 15839349
9. Krieger T Sauer OA: Monte Carlo- versus pencil-beam-/collapsed-cone-dose calculation in a heterogeneous multi-layer phantom. Phys Med Biol 2005, 50:859-868. 10.1088/0031-9155/50/5/010 15798260
10. Fogliata A Nicolini G Vanetti E Clivio A Winkler P Cozzi L: The impact of photon dose calculation algorithms on expected dose distributions in lungs under different respiratory phases. Phys Med Biol 2008, 53:2375-2390. 10.1088/0031-9155/53/9/011 18421117
11. Ding GX Duggan DM Lu B Hallahan DE Cmelak A Malcolm A Newton J Deeley M Coffey CW: Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy. Med Phys 2007, 34:2985-2994. 10.1118/1.2745923 17822007
12. Haedinger U Krieger T Flentje M Wulf J: Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets. Int J Radiat Oncol Biol Phys 2005, 61:239-249. 15629617
13. Panettieri V Wennberg B Gagliardi G Duch MA Ginjaume M Lax I: SBRT of lung tumours: Monte Carlo simulation with PENELOPE of dose distributions including respiratory motion and comparison with different treatment planning systems. Phys Med Biol 2007, 52:4265-4281. 10.1088/0031-9155/52/ 14/016 17664607
14. Hansen AT Petersen JB Hoyer M Christensen JJ: Comparison of two dose calculation methods applied to extracranial stereotactic radiotherapy treatment planning. Radiother Oncol 2005, 77:96-98. 10.1016/ j.radonc.2005.04.018 16246744
15. de Jaeger K Hoogeman MS Engelsman M Seppenwoolde Y Damen EFM Mijnheer BJ Boersma LJ Lebesque JV: Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: Re-evaluation of dose in normal lung tissue. Radiother Oncol 2003, 69:1-10. 10.1016/ S0167-8140(03)00195-6 14597351
16. Chang DT Olivier KR Morris CG Liu C Dempsey JF Benda RK Palta JR: The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. Int J Radiat Oncol Biol Phys 2006, 65:125-131. 16427214
17. Brink C Berg M Nielsen M: Sensitivity of NTCP parameter values against a change of dose calculation algorithm. Med Phys 2007, 34:3579-3586. 10.1118/1.2767983 17926961
18. Vanderstraeten B Reynaert N Paelinck L Madani I de Wagter C de Gersem W de Neve W Thierens H: Accuracy of patient dose calculation for lung IMRT: A comparison of Monte Carlo, convolution/superposition, and pencil beam computations. Med Phys 2006, 33:3149-3158. 10.1118/1.2241992 17022207